PRECISION BIOSCIENCES ($DTIL) posted quarterly earnings results on Monday, November 3rd. The company reported earnings of -$1.84 per share, missing estimates of -$1.37 by $0.47. The company also reported revenue of $10,000, missing estimates of $5,508,000 by $-5,498,000.
You can see Quiver Quantitative's $DTIL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PRECISION BIOSCIENCES Insider Trading Activity
PRECISION BIOSCIENCES insiders have traded $DTIL stock on the open market 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DTIL stock by insiders over the last 6 months:
- JOHN ALEXANDER KELLY (Chief Financial Officer) sold 14,827 shares for an estimated $63,163
- KEVIN BUEHLER purchased 5,076 shares for an estimated $21,116
- MELINDA BROWN has made 2 purchases buying 3,082 shares for an estimated $13,809 and 0 sales.
- STANLEY FRANKEL purchased 2,700 shares for an estimated $13,419
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PRECISION BIOSCIENCES Hedge Fund Activity
We have seen 27 institutional investors add shares of PRECISION BIOSCIENCES stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLEICHROEDER LP added 1,062,923 shares (+8801.2%) to their portfolio in Q2 2025, for an estimated $4,464,276
- LYNX1 CAPITAL MANAGEMENT LP added 270,000 shares (+35.2%) to their portfolio in Q2 2025, for an estimated $1,134,000
- BALYASNY ASSET MANAGEMENT L.P. removed 189,665 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $796,593
- VANGUARD GROUP INC added 124,271 shares (+44.2%) to their portfolio in Q2 2025, for an estimated $521,938
- CORIENT PRIVATE WEALTH LLC added 101,206 shares (+inf%) to their portfolio in Q2 2025, for an estimated $425,065
- MILLENNIUM MANAGEMENT LLC removed 65,586 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $275,461
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 61,901 shares (+inf%) to their portfolio in Q2 2025, for an estimated $259,984
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PRECISION BIOSCIENCES Analyst Ratings
Wall Street analysts have issued reports on $DTIL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 05/21/2025
To track analyst ratings and price targets for PRECISION BIOSCIENCES, check out Quiver Quantitative's $DTIL forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
